Submitted by Anonymous (not verified) on 6 October 2026 - 13:10
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 14, Status: Authorised